Drug-Induced Gingival Overgrowth.
Tungare S, Paranjpe AG.
2022 Sep 19. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions.
Chapple ILC, Mealey BL, Van Dyke TE, Bartold PM, Dommisch H, Eickholz P, Geisinger ML, Genco RJ, Glogauer M, Goldstein M, Griffin TJ, Holmstrup P, Johnson GK, Kapila Y, Lang NP, Meyle J, Murakami S, Plemons J, Romito GA, Shapira L, Tatakis DN, Teughels W, Trombelli L, Walter C, Wimmer G, Xenoudi P, Yoshie H.
J Periodontol. 2018 Jun;89 Suppl 1:S74-S84. doi: 10.1002/JPER.17-0719.
Cyclosporine-induced gingival overgrowth-Review.
Chojnacka-Purpurowicz J, Wygonowska E, Placek W, Owczarczyk-Saczonek A.
Dermatol Ther. 2022 Dec;35(12):e15912. doi: 10.1111/dth.15912. Epub 2022 Oct 17.
Drug-Induced Gingival Hyperplasia in a Hypertensive Patient: A Case Report.
Bakshi SS, Choudhary M, Agrawal A, Chakole S.
Cureus. 2023 Feb 2;15(2):e34558. doi: 10.7759/cureus.34558. eCollection 2023 Feb.
Drug-induced gingival hyperplasia - experimental model.
Goriuc A, Foia LG, Minea B, Luchian AI, Surdu AE, Toma V, Costuleanu M, Mârţu I.
Rom J Morphol Embryol. 2017;58(4):1371-1376.
Drug-Induced Oral Complications.
Ikeda K.
Atlas Oral Maxillofac Surg Clin North Am. 2017 Sep;25(2):127-132. doi: 10.1016/j.cxom.2017.04.005.
Drug-induced gingival hyperplasia--a review.
Varnfield M, Botha SJ.
SADJ. 2000 Nov;55(11):632-41.
Drug-induced gingival enlargements.
Desai P, Silver JG.
J Can Dent Assoc. 1998 Apr;64(4):263-8.
Drug-induced gingival hyperplasia.
[No authors listed]
Prescrire Int. 2011 Dec;20(122):293-4.
Drug-induced gingival hyperplasia and its management--a literature review.
Botha PJ.
J Dent Assoc S Afr. 1997 Nov;52(11):659-64.
